Dr Lawrence S Zachary, MD | |
4646 N Marine Dr, 5b, Chicago, IL 60640-5759 | |
(773) 564-6120 | |
(773) 564-6121 |
Full Name | Dr Lawrence S Zachary |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 46 Years |
Location | 4646 N Marine Dr, Chicago, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477646222 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 036060230 (Illinois) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Resilience Healthcare - Lakefront Medical Associates Llc | 5991046468 | 45 |
News Archive
Researchers from Johns Hopkins have found that dense mats of interacting bacteria, called biofilms, were present in the majority of cancers and polyps, particularly those on the right side of the colon. The presence of these bacterial bunches, they say, may represent an increased risk for colon cancer and could form the basis of new diagnostic tests.
Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Cetirizine Hydrochloride Tablets, 5 and 10 mg.
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that measuring the fetal zone of the adrenal gland is a better predictor of pre-term birth than measuring cervical length.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
› Verified 3 days ago
Entity Name | University Of Chicago |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821048786 PECOS PAC ID: 7719899426 Enrollment ID: O20031103000094 |
News Archive
Researchers from Johns Hopkins have found that dense mats of interacting bacteria, called biofilms, were present in the majority of cancers and polyps, particularly those on the right side of the colon. The presence of these bacterial bunches, they say, may represent an increased risk for colon cancer and could form the basis of new diagnostic tests.
Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Cetirizine Hydrochloride Tablets, 5 and 10 mg.
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that measuring the fetal zone of the adrenal gland is a better predictor of pre-term birth than measuring cervical length.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
› Verified 3 days ago
Entity Name | The University Of Chicago Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033218128 PECOS PAC ID: 7618880766 Enrollment ID: O20031106000203 |
News Archive
Researchers from Johns Hopkins have found that dense mats of interacting bacteria, called biofilms, were present in the majority of cancers and polyps, particularly those on the right side of the colon. The presence of these bacterial bunches, they say, may represent an increased risk for colon cancer and could form the basis of new diagnostic tests.
Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Cetirizine Hydrochloride Tablets, 5 and 10 mg.
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that measuring the fetal zone of the adrenal gland is a better predictor of pre-term birth than measuring cervical length.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
› Verified 3 days ago
Entity Name | Resilience Healthcare - Lakefront Medical Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205301926 PECOS PAC ID: 5991046468 Enrollment ID: O20190410000827 |
News Archive
Researchers from Johns Hopkins have found that dense mats of interacting bacteria, called biofilms, were present in the majority of cancers and polyps, particularly those on the right side of the colon. The presence of these bacterial bunches, they say, may represent an increased risk for colon cancer and could form the basis of new diagnostic tests.
Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Cetirizine Hydrochloride Tablets, 5 and 10 mg.
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that measuring the fetal zone of the adrenal gland is a better predictor of pre-term birth than measuring cervical length.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lawrence S Zachary, MD 4646 N Marine Dr, 5b, Chicago, IL 60640-5759 Ph: (773) 564-6120 | Dr Lawrence S Zachary, MD 4646 N Marine Dr, 5b, Chicago, IL 60640-5759 Ph: (773) 564-6120 |
News Archive
Researchers from Johns Hopkins have found that dense mats of interacting bacteria, called biofilms, were present in the majority of cancers and polyps, particularly those on the right side of the colon. The presence of these bacterial bunches, they say, may represent an increased risk for colon cancer and could form the basis of new diagnostic tests.
Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Cetirizine Hydrochloride Tablets, 5 and 10 mg.
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that measuring the fetal zone of the adrenal gland is a better predictor of pre-term birth than measuring cervical length.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
› Verified 3 days ago
Parit A Patel, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 737 N Michigan Ave Ste 1820, Chicago, IL 60611 Phone: 312-819-5338 Fax: 312-819-5337 | |
Akira Yamada, Plastic Surgery Medicare: Medicare Enrolled Practice Location: 225 E Chicago Ave, Division Of Plastic Surgery, Chicago, IL 60611 Phone: 312-227-6258 Fax: 312-227-9408 | |
Lyndsay Ann Kandi, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5841 S Maryland Ave # Mc6035, Chicago, IL 60637 Phone: 773-702-6302 Fax: 773-702-1634 | |
Dr. Diane L Gerber, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 250 E Pearson St, #2803, Chicago, IL 60611 Phone: 312-280-8707 | |
Stephanie Bond, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5841 S Maryland Ave # Mc6035, Chicago, IL 60637 Phone: 773-795-1240 | |
Anne Huang, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5841 S Maryland Ave # Mc6035, Chicago, IL 60637 Phone: 773-795-1240 Fax: 773-702-1634 | |
Maria Alexandra Artunduaga, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5841 S Maryland Ave, Mc 6035, Chicago, IL 60637 Phone: 773-795-1240 |